Easee v Visibly (CoA, 26 June 2025)
| Date | 26 June 2025 |
|---|---|
| Court | CoA |
| Division | Luxembourg (LU) |
| Type of action | Application Rop 223 |
| Case number(s) | UPC_CoA_542/2025 |
| Registry reference | App_28639/2025 · UPC_CoA_542/2025 |
| Parties | Easee B.V., ***, Easee Holding B.V. v. Visibly Inc. |
Official decision (PDF) · UPC registry entry
Dhenne Avocats represents claimants and defendants in European patent disputes before the Unified Patent Court, including the Paris divisions.
Dhenne Avocats · 10 October 2026
Our analysis
Summary
By order of 26 June 2025, the Court of Appeal (Kalden, Rombach, Simonsson) granted suspensive effect to the appeal of Easee’s managing director against the Hamburg Local Division’s order of 30 May 2025 requiring EUR 75,000 security for costs in respect of the counterclaim for revocation of EP 3 918 974, and provisional suspensive effect to the appeal of the bankrupt Easee companies (UPC_CoA_542/2025). The impugned order was manifestly wrong in light of AorticLab v Emboline: security may only be ordered in favour of the defendant.
Question
Should an order requiring a defendant, as counterclaimant for revocation, to provide security for costs to the patentee be deprived of effect pending appeal?
Decision
Suspensive effect remains exceptional under Art. 74(1) UPCA, it is justified where the impugned order is manifestly erroneous or enforcement would render the appeal largely pointless (paragraphs 12 and 13). Art. 69(4) UPCA does not allow security to be ordered at the claimant’s request, even in response to a counterclaim for revocation. The error is manifest (paragraphs 14 to 16) and no irreparable harm need be shown (paragraph 17). The insolvent companies obtain provisional suspensive effect pending a ruling on their counsel’s authority (paragraphs 18 and 19). No costs decision was made (paragraph 20).
Key points for practice
- Practical point: a patentee cannot obtain security for costs against the defendant, even in respect of a counterclaim for revocation, an order to the contrary may be suspended on appeal without proof of irreparable harm.
Provisions applied
- Agreement on a Unified Patent Court
- Art. 69(4), Art. 74(1)
- Rules of Procedure
- Rule 223
- Case law cited
- Meril v Edwards, 18 January 2024, ICPillar, 19 June 2024, Sibio v Abbott Diabetes Care, 19 August 2024, Ocado Innovation v Third Party, 6 November 2023, Progress Maschinen & Automation, 2 May 2024, Koninklijke Philips v Belkin, 29 October 2024, AorticLab v Emboline, 20 June 2025
Related decisions
Prepared by Dhenne Avocats from the official decision, consulted on 10 October 2026. The database is updated every week, on Friday. Only the official text is authoritative.
Going further
Lexicon: UPC Court of Appeal.
Dhenne Avocats blog: UPC Appeals: What the Numbers Show.
Source and translations
- Official source
- Unified Patent Court registry link recorded in the record
- Original language
- not recorded
- Translation available
- no translation recorded the firm’s French record is a summary, not a translation
- Date checked
- not recorded
Follow this case
Proceedings, related decisions, appeals, parties and patents as recorded in the registry and in the Dhenne Avocats corpus. Each link states its source.
Parties
- defendantVisibly Inc.5 decisions in the corpusFollow this party
- claimantEasee Holding B.V.5 decisions in the corpusFollow this party
- claimantEasee B.V., ***5 decisions in the corpusFollow this party
Decisions in the same proceedings and documented appeals
What the record states
- Nature of the act
- Application Rop 223
- Outcome (Dhenne Avocats summary)
- La cour d'appel accorde l'effet suspensif à l'appel du dirigeant d'Easee et, à titre provisoire, à celui des sociétés Easee, l'ordonnance de garantie pour frais au profit du titulaire étant manifestement erronée.
- Appeal
- Decision of the Court of Appeal.
- Instance
- Court of Appeal decision.
Patents mentioned
EP 3 918 974mentioned in: Dhenne Avocats analysis Follow this patent
Related decisions cited in the analyses
- Easee v Visibly (CoA, 1 July 2025) cited in this record
- Visibly v Easee (CFI, 26 June 2025) cited in this record
- AorticLab v Emboline (CoA, 20 June 2025) cited in this record
- Visibly v Easee (CFI, 30 May 2025) cited in this record
- Koninklijke Philips v Belkin (CoA, 29 October 2024) cited in this record
- Sibio v Abbott Diabetes Care (CoA, 19 August 2024) cited in this record
- ICPillar v ARM (CoA, 19 June 2024) cited in this record
- Progress Maschinen & Automation v AWM (CoA, 2 May 2024) cited in this record
- Meril Life Sciences v Edwards Lifesciences (CoA, 18 January 2024) cited in this record
- Ocado Innovation v Third Party (CoA, 6 November 2023) cited in this record
Patents and standards
| Publication | Role in the dispute | Family | Standard and declaration | Pool | Sources |
|---|---|---|---|---|---|
EP 3 918 974 | Mentioned in the analysis (role not qualified) Also mentioned in 6 other decision(s): Visibly v Easee (CoA, 23 July 2025) · Easee v Visibly (CoA, 1 July 2025) · Visibly v Easee (CFI, 26 June 2025) · Visibly v Easee (CFI, 30 May 2025) · Yves Prevoo v Visibly (CFI, 18 December 2024) · Easee v Visibly (CFI, 24 October 2024) | not recorded | not recorded | not recorded | Espacenet links not checked mentioned in: Dhenne Avocats analysis |
Receive an alert
Weekly summary of new records and substantive updates matching what you follow. Address confirmed by email, unsubscribe at any time, one email per week even where several of your follows match.